Workflow
Alcon(ALC)
icon
搜索文档
Broadwood Partners Issues Letter to STAAR Surgical's Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale
Businesswire· 2025-10-11 01:11
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, "Broadwood†) today issued the following letter to the Board of Directors (the "Board†) of STAAR Surgical Company ("STAAR†or the "Company†) (NASDAQ: STAA). Broadwood, which owns 27.5% of STAAR's outstanding common shares, continues to urge its fellow shareholders to vote on its GREEN Proxy Card "AGAINST†the proposed acquisition of STAAR by Alcon Inc. ("Alcon†) (NYSE: ALC) on the terms announced August 5, 2025. ...
STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote “FOR” the Alcon Merger Agreement on WHITE Proxy Card
Businesswire· 2025-10-08 23:40
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA) ("STAAR†), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICLâ"¢) for vision correction, today provided the following statement in response to a report issued by Glass, Lewis & Co., LLC ("Glass Lewis†) related to STAAR's pending merger with Alcon (SIX/NYSE: ALC): The STAAR Board of Directors and management team strongly disagree with the recommendation issued by Glass Lewis. ...
Broadwood Partners: Leading Advisory Firm Glass Lewis Urges STAAR Shareholders to Vote “AGAINST” Sale to Alcon
Businesswire· 2025-10-08 23:16
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates ("Broadwood†or "we†) today announced that Glass, Lewis & Co., LLC ("Glass Lewis†), a leading independent proxy advisory firm, has recommended that the shareholders of STAAR Surgical Company ("STAAR†or the "Company†) (NASDAQ: STAA) vote "AGAINST†the proposed acquisition of STAAR by Alcon Inc. ("Alcon†) (NYSE: ALC) on the terms announced on August 5, 2025. "Glass Lewis's recommendation and findings underscore our strong. ...
Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon
Prnewswire· 2025-10-07 23:25
We have been significant STAAR shareholders for more than ten years and remain convicted in the significant value of the Company. The proposed sale of STAAR to Alcon for $28 per share significantly undervalues the Company, especially when considering the STAAR Board of Directors' rejection of Alcon's previous offer for $58 per share in cash only sixteen months ago. With recent positive projections and outlook released by management, we see no compelling reason to sell STAAR at this time. We are disappointed ...
STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis
Businesswire· 2025-10-06 19:31
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today highlighted commentary from numerous independent industry analysts who recognize that STAAR's merger with Alcon (SIX/NYSE: ALC) – and the compelling, certain, premium cash value it provides – is the best path forward for STAAR stockholders. Stephen Farrell, CEO of STAAR, said, "Prior to the Alcon. ...
Broadwood Partners Publishes Presentation Detailing Opposition to STAAR Surgical's Sale to Alcon
Businesswire· 2025-10-03 18:00
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, "Broadwood†), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company ("STAAR†or the "Company†) (NASDAQ: STAA), today announced that it has published a presentation outlining why stockholders should vote on Broadwood's GREEN Proxy Card "AGAINST†the proposed acquisition of the Company by an affiliate of Alcon Inc. (NYSE: ALC) on the terms announced on August 5, 2025. The 81-pa. ...
Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon's Acquisition of STAAR
Businesswire· 2025-09-30 20:30
GENEVA & LAKE FOREST, Calif.--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA) ("STAAR†), the manufacturer of the Implantable Collamer® Lens (ICL), today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (HSR), in connection with Alcon's acquisition of STAAR, expired at 11:59 p.m. ET on September 29, 2025. As previously announced,. ...
Alcon: Seeing Is Believing As Buyout Of STAAR Surgical Hangs In Balance (NYSE:ALC)
Seeking Alpha· 2025-09-29 20:47
作者背景 - 作者Albert Anthony为克罗地亚裔美国商业作家 在投资者平台Seeking Alpha拥有超过1000名粉丝 [1] - 作者在Investing com等平台撰稿 并计划于2025年在亚马逊出版关于房地产投资信托基金基本面分析的书籍 [1] - 作者拥有非传统金融背景 曾在美国数家财富500强公司担任IT分析师 并于2021年在金融公司嘉信理财的技术支持团队工作 [1] - 作者在纽约市长大 后定居德克萨斯州奥斯汀 并参与克罗地亚欧盟市场的数十场商业、创新会议和小组讨论 [1] - 作者毕业于德鲁大学 目前正就读于温哥华企业金融学院的资本市场与证券分析师认证课程 [1] 业务范围 - 作者运营其个人股票研究公司Albert Anthony & Company 并100%远程管理 [1] - 作者专注于公开上市公司 不涉及非上市公司、小盘股或初创公司首席执行官相关内容 [1] - 作者活跃于数字媒体 在欧洲演艺机构有参与超过5部作品的演出 并在克罗地亚地区媒体频道出现 [1] - 作者正在发展其YouTube频道Albert Anthony 将讨论房地产投资信托基金相关内容 [1]
Alcon: Seeing Is Believing As Buyout Of STAAR Surgical Hangs In Balance
Seeking Alpha· 2025-09-29 20:47
作者背景 - 作者Albert Anthony是克罗地亚裔美国商业作家 在投资者平台Seeking Alpha拥有超过1000名追随者并为Investing com等平台撰稿 [1] - 作者计划于2025年在亚马逊推出一本名为《房地产投资信托基金:基本面分析》的书籍 [1] - 作者拥有非传统金融背景 曾在美国多家财富500强公司担任IT行业分析师 并于2021年在金融公司嘉信理财的技术支持团队工作 [1] 专业活动 - 作者创立并100%远程管理自己的股票研究公司Albert Anthony & Company [1] - 作者曾参与克罗地亚数十场商业与创新会议、贸易展览和小组讨论 [1] - 作者正在攻读温哥华企业金融学院的资本市场与证券分析师认证课程 [1] 媒体参与 - 作者活跃于欧洲选角机构 在超过5部制作中担任过临时角色 并为克罗地亚地区媒体频道供稿或出镜 [1] - 作者正在发展其YouTube频道Albert Anthony 将讨论房地产投资信托基金相关内容 [1]
Algoma Central Corporation Celebrates 100th Vessel Milestone
Businesswire· 2025-09-26 20:26
ST. CATHARINES, Ontario--(BUSINESS WIRE)-- #yourmarinecarrierofchoice--Algoma Central Corporation ("Algoma† or "the Company† of three new methanol-ready Kamsarmax-sized ocean belt self-unloading vessels. With this addition, the Company will have an ownership interest in 100 vessels across its global fleet, a historic milestone that underscores its leadership in long-term growth in diversified short sea shipping markets. "This is a proud moment on two fronts: t. ...